GO:0160178 dipeptide uniporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0160178 dipeptide uniporter activity describes the catalysis of dipeptide transport across a membrane without coupling to any other molecular species.
• Dipeptide uniport is distinct from proton-coupled peptide transport (PepT1/PepT2) and is critical for nutrient absorption and drug delivery.
• Key proteins include SLC15A1 (PepT1), SLC15A2 (PepT2), and SLC15A4, though their coupling mechanisms vary.
• The term is a molecular function; it does not imply a specific biological process or cellular component, but is often studied in intestinal and renal epithelia.
• Dysregulation of dipeptide transport is linked to inflammatory bowel disease, cancer, and metabolic disorders.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect the role of individual transporters in dipeptide uniport.
Description
Dipeptide uniporter activity (GO:0160178) is a molecular function defined as the catalysis of dipeptide transport across a membrane, independent of the movement of any other molecular species. This activity is fundamental to nutrient absorption, as dipeptides are a major source of amino acids in the diet. Unlike proton-coupled peptide transporters, which rely on a proton gradient, uniporters facilitate the movement of dipeptides down their concentration gradient without coupling to other ions or molecules. Understanding this activity is crucial for researchers studying intestinal and renal physiology, drug delivery, and metabolic diseases. The term is part of the Gene Ontology (GO) molecular function aspect and is often studied in the context of solute carrier (SLC) transporters.
dipeptide uniporter activity At A Glance
| GO ID | GO:0160178 |
|---|---|
| GO term | dipeptide uniporter activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of dipeptide transport across a membrane, independent of other species |
| Major genes | SLC15A1, SLC15A2, SLC15A4 |
| Related diseases | Inflammatory bowel disease, cancer, metabolic disorders |
| Research methods | CRISPR knockout, knock-in, overexpression, transport assays |
What Is GO:0160178?
According to the Gene Ontology, dipeptide uniporter activity (GO:0160178) is defined as the catalysis of the transport of a dipeptide across a membrane; transport is independent of the movement of any other molecular species. This means the transporter moves a dipeptide from one side of a membrane to the other without requiring the simultaneous transport of another ion or molecule, such as a proton or sodium ion.
Why Is dipeptide uniporter activity Important in Cell Biology?
Dipeptide uniporter activity is essential for the absorption of dietary dipeptides and the reabsorption of dipeptides in the kidney, playing a key role in amino acid homeostasis. It also influences the pharmacokinetics of peptide-based drugs, as many prodrugs are designed to exploit dipeptide transporters for improved oral bioavailability. Moreover, dysregulation of dipeptide transport has been implicated in inflammatory bowel disease and cancer, making it a potential therapeutic target.
• Facilitates dietary dipeptide absorption in the small intestine.
• Mediates renal reabsorption of dipeptides, preventing amino acid loss.
• Enables transport of peptide-based prodrugs, enhancing drug delivery.
• Linked to inflammatory bowel disease pathogenesis.
• Potential role in cancer metabolism and drug resistance.
• Target for improving oral bioavailability of peptide drugs.
• Involved in amino acid sensing and mTOR signaling.
• Regulated by calcium signaling and pH.
• Genetic variants affect transport efficiency and disease risk.
• CRISPR models enable precise functional dissection.
Mechanism, Genes and Research Methods
Substrate Recognition and Binding
In simple terms: The transporter first grabs the dipeptide.
Dipeptide uniporters recognize and bind dipeptides with high specificity, often preferring dipeptides with certain amino acid compositions. Binding occurs at a substrate-binding site within the transporter's transmembrane domain, and this step is independent of proton or ion gradients. Structural studies of related transporters suggest that substrate binding induces conformational changes that facilitate transport.
Conformational Change and Translocation
In simple terms: The transporter changes shape to move the dipeptide across the membrane.
Upon substrate binding, the transporter undergoes a series of conformational changes that expose the substrate to the opposite side of the membrane. This alternating access mechanism allows the dipeptide to be released into the cytoplasm or extracellular space, depending on the direction of transport. The process is driven by the concentration gradient of the dipeptide and does not require ATP or coupling to other ions.
Release and Reset
In simple terms: The dipeptide is released, and the transporter resets for another round.
After translocation, the dipeptide is released, and the transporter returns to its original conformation, ready for another cycle. This uniport mechanism is distinct from proton-coupled transporters, which require proton symport. The rate of transport can be influenced by substrate concentration, membrane potential, and regulatory factors.
Regulation by Calcium and pH
In simple terms: Calcium and pH can tweak how well the transporter works.
Intracellular calcium signaling and pH have been shown to regulate dipeptide absorption. For example, the calcium-sensing receptor (CaSR) modulates intestinal dipeptide absorption via Ca2+ signaling and IKCa activation. Additionally, intracellular pH regulation in skeletal muscle affects insulin signaling and nutrient transport. These regulatory mechanisms ensure that dipeptide transport adapts to metabolic demands.
Key Genes Involved in GO:0160178 dipeptide uniporter activity
The following genes encode proteins that exhibit or are associated with dipeptide uniporter activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC15A1 | Intestinal dipeptide transporter (PepT1) | Nutrient absorption, drug delivery |
| SLC15A2 | Renal dipeptide transporter (PepT2) | Renal reabsorption, drug clearance |
| SLC15A4 | Endolysosomal dipeptide transporter | Immune signaling, autoimmunity |
| SLC15A3 | Endolysosomal transporter | Antigen presentation |
| SLC15A5 | Orphan transporter | Unknown function |
| SLC7A5 | Amino acid transporter | mTOR signaling |
| SLC3A2 | Amino acid transporter subunit | mTOR signaling |
| SLC38A2 | Amino acid transporter | Nutrient sensing |
| SLC36A1 | Proton-coupled amino acid transporter | Drug transport |
| SLC6A19 | Amino acid transporter | Hartnup disorder |
| SLC7A8 | Amino acid transporter | Nutrient absorption |
| SLC43A1 | Amino acid transporter | Metabolism |
| SLC43A2 | Amino acid transporter | Metabolism |
| SLC1A5 | Glutamine transporter | Cancer metabolism |
| SLC7A11 | Cystine/glutamate transporter | Oxidative stress |
| SLC25A12 | Mitochondrial aspartate/glutamate carrier | Metabolism |
| SLC25A13 | Mitochondrial aspartate/glutamate carrier | Metabolism |
How Is dipeptide uniporter activity Regulated?
Dipeptide uniporter activity is regulated at multiple levels. Intracellular calcium signaling via the calcium-sensing receptor (CaSR) enhances intestinal dipeptide absorption through Ca2+-activated IKCa channels. Intracellular pH also modulates transport activity, as changes in pH can affect transporter conformation and substrate affinity. Additionally, insulin signaling and mTOR pathways influence nutrient transporter expression and function. In endosomes, the V-ATPase and RILP regulate late endosomal pH, which may impact SLC15A4-mediated dipeptide transport.
dipeptide uniporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC15A1 | Inflammatory bowel disease | Intestinal epithelial KO mice |
| SLC15A2 | Renal reabsorption disorders | Renal tubule KO mice |
| SLC15A4 | Autoimmunity, cancer | Endolysosomal KO cell lines |
| SLC7A5 | Cancer metabolism | Tumor xenograft KO |
| SLC1A5 | Cancer metabolism | Cancer cell line KO |
Inflammatory Bowel Disease
Altered dipeptide transport has been observed in inflammatory bowel disease (IBD), where inflammation may affect the expression and function of dipeptide transporters such as SLC15A1. The calcium-sensing receptor (CaSR) regulates intestinal dipeptide absorption, and its dysfunction may contribute to IBD pathogenesis. Targeting dipeptide transport could offer therapeutic benefits in IBD.
Cancer
Dipeptide transporters are often upregulated in cancer cells to support increased nutrient demands. For example, SLC15A1 and SLC15A2 may facilitate the uptake of peptide-based drugs, influencing chemotherapy efficacy. Additionally, endolysosomal transporters like SLC15A4 are implicated in immune signaling pathways that can promote tumorigenesis.
Metabolic Disorders
Dipeptide uniport contributes to amino acid homeostasis, and its dysregulation is linked to metabolic disorders such as insulin resistance. Intracellular pH regulation in skeletal muscle affects insulin signaling and nutrient transport, suggesting a role for dipeptide transporters in metabolic health.
Ocular Herpes Infections
Dipeptide prodrugs of acyclovir exploit dipeptide transporters for enhanced ocular delivery, improving treatment of herpes infections. This highlights the therapeutic potential of targeting dipeptide uniport for drug delivery.
From dipeptide uniporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC15A1 mediate intestinal dipeptide uniport? | SLC15A1 knockout Caco-2 cells |
| What is the role of SLC15A4 in endosomal transport? | SLC15A4 knockout macrophages |
| Can a point mutation alter substrate specificity? | CRISPR knock-in of mutant SLC15A1 |
| Does overexpression enhance drug uptake? | SLC15A1 overexpression in HEK293 cells |
| How does pH regulate dipeptide transport? | pH-sensitive fluorescent probes in live cells |
| What is the impact of CaSR on dipeptide absorption? | CaSR knockout intestinal organoids |
How to Study the dipeptide uniporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled dipeptide uptake | Transport rate and kinetics | Intestinal absorption studies |
| CRISPR knockout | Loss-of-function effects | Gene function validation |
| Knock-in of point mutations | Effect of specific mutations | Structure-function analysis |
| Overexpression | Gain-of-function effects | Drug uptake enhancement |
| Live-cell pH imaging | Intracellular pH changes | Regulation by pH |
| RNA-seq | Gene expression changes | Pathway analysis |
| Proteomics | Protein abundance and modifications | Regulatory mechanisms |
Transport Assays
Radiolabeled or fluorescently labeled dipeptides are used to measure transport rates across cell monolayers or membrane vesicles. These assays can determine kinetics, substrate specificity, and the effect of inhibitors.
CRISPR-Cas9 Genome Editing
Knockout, knock-in, and overexpression models are generated to study the function of specific transporters. For example, SLC15A1 knockout cells show reduced dipeptide uptake, confirming its role.
Live-Cell Imaging
Fluorescent pH indicators and tagged transporters enable real-time visualization of transport and regulation. This method reveals dynamic changes in intracellular pH and transporter localization.
Proteomics and Transcriptomics
RNA-seq and proteomics identify expression changes in transporters under different conditions, such as inflammation or metabolic stress. These approaches can uncover novel regulators of dipeptide uniport.
How CRISPR Can Be Used to Study GO:0160178 dipeptide uniporter activity
Knockout
CRISPR knockout of dipeptide transporter genes (e.g., SLC15A1) abolishes transport activity, allowing researchers to confirm the gene's role in dipeptide uniport. This approach is valuable for studying nutrient absorption and drug delivery.
Point Mutation
Introducing point mutations in transporter genes via CRISPR can reveal critical residues for substrate binding or conformational changes. Such models help dissect the molecular mechanism of uniport.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC15A1) enables visualization and tracking of the protein in live cells. This is useful for studying localization and dynamics.
Overexpression
Overexpression of dipeptide transporters in cell lines enhances transport capacity, facilitating drug uptake studies and high-throughput screening. This model is particularly useful for testing prodrug delivery.
How EDITGENE Supports dipeptide uniporter activity Research
Researchers studying dipeptide uniporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, how mutations affect function, and whether overexpression can enhance drug delivery. EDITGENE provides comprehensive CRISPR services to address these questions with precision and efficiency.
Contact EDITGENE today to design your custom CRISPR model for dipeptide uniporter activity research.
Frequently Asked Questions About dipeptide uniporter activity
What is dipeptide uniporter activity?
Dipeptide uniporter activity (GO:0160178) is the catalysis of dipeptide transport across a membrane, independent of the movement of any other molecular species.
What genes are involved in dipeptide uniporter activity?
Key genes include SLC15A1, SLC15A2, and SLC15A4, which encode transporters that mediate dipeptide uniport.
How is dipeptide uniporter activity regulated?
It is regulated by intracellular calcium signaling, pH, and insulin/mTOR pathways.
What diseases are associated with dipeptide uniporter activity?
Dysregulation is linked to inflammatory bowel disease, cancer, metabolic disorders, and ocular herpes infections.
What methods are used to study dipeptide uniporter activity?
Common methods include radiolabeled uptake assays, CRISPR knockout, live-cell imaging, and proteomics.
Can CRISPR be used to study dipeptide uniporter activity?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect gene function.
What is the difference between dipeptide uniporter and proton-coupled peptide transport?
Uniporters do not couple to proton movement, whereas proton-coupled transporters rely on a proton gradient.
Which cell types express dipeptide uniporters?
They are highly expressed in intestinal epithelial cells and renal tubular cells.
How does pH affect dipeptide uniporter activity?
Intracellular pH changes can alter transporter conformation and activity.
What is the role of SLC15A4 in dipeptide uniport?
SLC15A4 is an endolysosomal transporter involved in immune signaling and autoimmunity.
Conclusion
Dipeptide uniporter activity (GO:0160178) is a vital molecular function that enables the transport of dipeptides across membranes without coupling to other species. Its role in nutrient absorption, drug delivery, and disease makes it a compelling target for research. Understanding the genes and regulatory mechanisms involved can lead to new therapeutic strategies. EDITGENE provides the CRISPR tools and services needed to advance this field.
References
- 1. Mulligan RJ et al.. 2024. Collapse of late endosomal pH elicits a rapid Rab7 response via the V-ATPase and RILP.. J Cell Sci 137(9) PMID: 38578235
- 2. Siddiqi SA et al.. 2000. Nutrient absorption.. Curr Opin Gastroenterol 16(2):147-53 PMID: 17024033
- 3. Anand B et al.. 2003. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.. Curr Eye Res 26(3-4):151-63 PMID: 12815543
- 5. Posa DK et al.. 2020. Intracellular pH Regulation of Skeletal Muscle in the Milieu of Insulin Signaling.. Nutrients 12(10) PMID: 32977552
- 6. Xu J et al.. 2020. Calcium-sensing receptor regulates intestinal dipeptide absorption via Ca(2+) signaling and IK(Ca) activation.. Physiol Rep 8(1):e14337 PMID: 31960592
- 7. Ganapathy V et al.. 1991. Proton-coupled solute transport in the animal cell plasma membrane.. Curr Opin Cell Biol 3(4):695-701 PMID: 1663375
